Dark, Then Dawn: ANDA Workload Approaching Steady State After 2014 Eruption
FDA Office of Generic Drugs' output is beginning to compete with, rather than be overwhelmed by, sponsors' input.
FDA Office of Generic Drugs' output is beginning to compete with, rather than be overwhelmed by, sponsors' input.